Garg A. Acquired and inherited lipodystrophies. N Engl J Med. 2004;350(12):1220–34.

CAS  PubMed  Article  Google Scholar 

Chiquette E, et al. Estimating the prevalence of generalized and partial lipodystrophy: findings and challenges. Diabetes Metab Syndr Obes. 2017;10:375–83.

PubMed  PubMed Central  Article  Google Scholar 

Andre P, et al. Metabolic and cardiac phenotype characterization in 37 atypical Dunnigan patients with nonfarnesylated mutated prelamin A. Am Heart J. 2015;169(4):587–93.

CAS  PubMed  Article  Google Scholar 

Gonzaga-Jauregui C, et al. Clinical and Molecular prevalence of lipodystrophy in an unascertained large clinical care cohort. Diabetes. 2020;69(2):249–58.

CAS  PubMed  Article  Google Scholar 

Udler MS, et al. Type 2 diabetes genetic loci informed by multi-trait associations point to disease mechanisms and subtypes: A soft clustering analysis. PLoS Med. 2018;15(9):e1002654.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Patni N, Garg A. Congenital generalized lipodystrophies--new insights into metabolic dysfunction. Nat Rev Endocrinol. 2015;11(9):522–34.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Misra A, Garg A. Clinical features and metabolic derangements in acquired generalized lipodystrophy: case reports and review of the literature. Medicine (Baltimore). 2003;82(2):129–46.

Article  Google Scholar 

Dunnigan MG, et al. Familial lipoatrophic diabetes with dominant transmission. A new syndrome Q J Med. 1974;43(169):33–48.

CAS  PubMed  Google Scholar 

Misra A, Peethambaram A, Garg A. Clinical features and metabolic and autoimmune derangements in acquired partial lipodystrophy: report of 35 cases and review of the literature. Medicine (Baltimore). 2004;83(1):18–34.

CAS  Article  Google Scholar 

Agarwal AK, et al. AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34. Nat Genet. 2002;31(1):21–3.

CAS  PubMed  Article  Google Scholar 

Magre J, et al. Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13. Nat Genet. 2001;28(4):365–70.

CAS  PubMed  Article  Google Scholar 

Kim CA, et al. Association of a homozygous nonsense caveolin-1 mutation with Berardinelli-Seip congenital lipodystrophy. J Clin Endocrinol Metab. 2008;93(4):1129–34.

CAS  PubMed  Article  Google Scholar 

Hayashi YK, et al. Human PTRF mutations cause secondary deficiency of caveolins resulting in muscular dystrophy with generalized lipodystrophy. J Clin Invest. 2009;119(9):2623–33.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Payne F, et al. Mutations disrupting the Kennedy phosphatidylcholine pathway in humans with congenital lipodystrophy and fatty liver disease. Proc Natl Acad Sci U S A. 2014;111(24):8901–6.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Rubio-Cabezas O, et al. Partial lipodystrophy and insulin resistant diabetes in a patient with a homozygous nonsense mutation in CIDEC. EMBO Mol Med. 2009;1(5):280–7.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Albert JS, et al. Null mutation in hormone-sensitive lipase gene and risk of type 2 diabetes. N Engl J Med. 2014;370(24):2307–15.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Farhan SM, et al. A novel LIPE nonsense mutation found using exome sequencing in siblings with late-onset familial partial lipodystrophy. Can J Cardiol. 2014;30(12):1649–54.

PubMed  Article  Google Scholar 

Donadille B, et al. Partial lipodystrophy with severe insulin resistance and adult progeria Werner syndrome. Orphanet J Rare Dis. 2013;8:106.

PubMed  PubMed Central  Article  Google Scholar 

Herbst KL, et al. Kobberling type of familial partial lipodystrophy: an underrecognized syndrome. Diabetes Care. 2003;26(6):1819–24.

PubMed  Article  Google Scholar 

Cao H, Hegele RA. Nuclear lamin A/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy. Hum Mol Genet. 2000;9(1):109–12.

CAS  PubMed  Article  Google Scholar 

Shackleton S, et al. LMNA, encoding lamin A/C, is mutated in partial lipodystrophy. Nat Genet. 2000;24(2):153–6.

CAS  PubMed  Article  Google Scholar 

Agarwal AK, Garg A. A novel heterozygous mutation in peroxisome proliferator-activated receptor gamma gene in a patient with familial partial lipodystrophy. J Clin Endocrinol Metab. 2002;87(1):408–11.

CAS  PubMed  Google Scholar 

George S, et al. A family with severe insulin resistance and diabetes due to a mutation in AKT2. Science. 2004;304(5675):1325–8.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Gandotra S, et al. Perilipin deficiency and autosomal dominant partial lipodystrophy. N Engl J Med. 2011;364(8):740–8.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Dyment DA, et al. Biallelic mutations at PPARG cause a congenital, generalized lipodystrophy similar to the Berardinelli-Seip syndrome. Eur J Med Genet. 2014;57(9):524–6.

CAS  PubMed  Article  Google Scholar 

Novelli G, et al. Mandibuloacral dysplasia is caused by a mutation in LMNA-encoding lamin A/C. Am J Hum Genet. 2002;71(2):426–31.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Agarwal AK, et al. Zinc metalloproteinase, ZMPSTE24, is mutated in mandibuloacral dysplasia. Hum Mol Genet. 2003;12(16):1995–2001.

CAS  PubMed  Article  Google Scholar 

Lessel D, et al. Mutations in SPRTN cause early onset hepatocellular carcinoma, genomic instability and progeroid features. Nat Genet. 2014;46(11):1239–44.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Cabanillas R, et al. Nestor-Guillermo progeria syndrome: a novel premature aging condition with early onset and chronic development caused by BANF1 mutations. Am J Med Genet A. 2011;155A(11):2617–25.

PubMed  Article  CAS  Google Scholar 

Eriksson M, et al. Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature. 2003;423(6937):293–8.

CAS  PubMed  Article  Google Scholar 

De Sandre-Giovannoli A, et al. Lamin a truncation in Hutchinson-Gilford progeria. Science. 2003;300(5628):2055.

PubMed  Article  Google Scholar 

Graul-Neumann LM, et al. Marfan syndrome with neonatal progeroid syndrome-like lipodystrophy associated with a novel frameshift mutation at the 3' terminus of the FBN1-gene. Am J Med Genet A. 2010;152A(11):2749–55.

CAS  PubMed  Article  Google Scholar 

Garg A, et al. Whole exome sequencing identifies de novo heterozygous CAV1 mutations associated with a novel neonatal onset lipodystrophy syndrome. Am J Med Genet A. 2015;167A(8):1796–806.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Weedon MN, et al. An in-frame deletion at the polymerase active site of POLD1 causes a multisystem disorder with lipodystrophy. Nat Genet. 2013;45(8):947–50.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Masotti A, et al. Keppen-Lubinsky syndrome is caused by mutations in the inwardly rectifying K+ channel encoded by KCNJ6. Am J Hum Genet. 2015;96(2):295–300.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Thauvin-Robinet C, et al. PIK3R1 mutations cause syndromic insulin resistance with lipoatrophy. Am J Hum Genet. 2013;93(1):141–9.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Agarwal AK, et al. PSMB8 encoding the beta5i proteasome subunit is mutated in joint contractures, muscle atrophy, microcytic anemia, and panniculitis-induced lipodystrophy syndrome. Am J Hum Genet. 2010;87(6):866–72.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Corvillo F, et al. Autoantibodies Against Perilipin 1 as a Cause of Acquired Generalized Lipodystrophy. Front Immunol. 2018;9:2142.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Garg A. Lipodystrophies. Am J Med. 2000;108(2):143–52.

CAS  PubMed  Article